T. R�nnemaa

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes

Peter R. Ebeling, A.-M. Teppo, Heikki A. Koistinen et al. · Diabetologia · 1999 · 96 citations · Full text

Metabolic Syndrome, Diabetes Management, Biochemistry +8

Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?

Markku Laakso, T. R�nnemaa, Seppo Lehto et al. · Diabetologia · 1995 · 67 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, High-risk Populations +10

Cardiac rehabilitation and return to work after coronary artery bypass surgery

Erik Engblom, H. H�m�l�inen, T. R�nnemaa et al. · Quality of Life Research · 1994 · 37 citations

Cardiac Surgery, Cardiac Rehabilitation, Rehabilitation +6

Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes

Jari Sundell, Tuula Janatuinen, T. R�nnemaa et al. · Diabetologia · 2004 · 30 citations · Full text

Type 1, Diabetic Retinopathy, Diabetic Background Retinopathy +8

High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes

Jari Sundell, T. R�nnemaa, Hanna Laine et al. · Diabetologia · 2004 · 16 citations · Full text

Metabolic Syndrome, Uncomplicated Type 1, Cardiovascular Disease +10